This market-timing model nailed the 2022 meltdown. Now it’s warning that stocks are a ‘dead cold sell.’
A little-known market timing indicator with a spot-on track record has just flashed a “dead cold sell” signal.
Hosted on MSN10h
Market strategist preparing for potential 'Fed mistake'
Shana Orczyk Sissel, founder and CEO of Banríon Capital Management, sees 2025 as a "volatile" year for stocks "with lower ...
Regeneron’s Pipeline Progress and Market Potential: Hold Rating Amidst Competitive Landscape
Regeneron (REGN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Geoff Meacham from ...
Stock market ‘finally paying more attention to tariffs’ as a potential headwind
Tariffs have taken the spotlight as a policy issue as S&P 500 companies have discussed earnings with analysts since the U.S.
AstraZeneca: Strong Growth Potential And Market Volatility Offer Opportunity
AstraZeneca PLC aims for $80 billion revenue by 2030 through strong growth in oncology, biopharmaceuticals, and rare diseases ...
Seeking Alpha28d
Bright Minds Biosciences: BMB-101's Phase 2 Trials Could Unlock Epilepsy Market Potential
The US market potential for this is approximately 230,000 patients. For developmental and epileptic encephalopathies [DEE], the patient population is estimated at 150,000 individuals, with a $2 ...
Nasdaq6d
The Potential Market and Policy Trends Under a Trump Administration
join Jill Malandrino on Nasdaq TradeTalks to discuss potential market and policy trends under a Trump administration. Sign up for our newsletter to get the latest on the transformative forces ...